JPH0655679B2 - 免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン - Google Patents

免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン

Info

Publication number
JPH0655679B2
JPH0655679B2 JP3269966A JP26996691A JPH0655679B2 JP H0655679 B2 JPH0655679 B2 JP H0655679B2 JP 3269966 A JP3269966 A JP 3269966A JP 26996691 A JP26996691 A JP 26996691A JP H0655679 B2 JPH0655679 B2 JP H0655679B2
Authority
JP
Japan
Prior art keywords
peptide
miep
protein
hiv
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3269966A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0616569A (ja
Inventor
アイ．オリフ アレン
エー．リウ マーガレット
フリードマン アーサー
ワイ．タイ ジョセフ
ジェー．ドネリー ジョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPH0616569A publication Critical patent/JPH0616569A/ja
Publication of JPH0655679B2 publication Critical patent/JPH0655679B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP3269966A 1990-07-19 1991-07-19 免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン Expired - Lifetime JPH0655679B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55532990A 1990-07-19 1990-07-19
US555329 1990-07-19
US71527491A 1991-06-19 1991-06-19
US715274 1991-06-19

Publications (2)

Publication Number Publication Date
JPH0616569A JPH0616569A (ja) 1994-01-25
JPH0655679B2 true JPH0655679B2 (ja) 1994-07-27

Family

ID=27070858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3269966A Expired - Lifetime JPH0655679B2 (ja) 1990-07-19 1991-07-19 免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン

Country Status (10)

Country Link
JP (1) JPH0655679B2 (no)
KR (1) KR920002632A (no)
AU (1) AU8113691A (no)
CA (1) CA2050635A1 (no)
FI (1) FI913475A7 (no)
IL (1) IL98839A0 (no)
MX (1) MX9100275A (no)
NO (1) NO912823L (no)
NZ (1) NZ238974A (no)
PT (1) PT98382A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323845T3 (es) * 1999-04-30 2009-07-27 Novartis Vaccines And Diagnostics, Inc. Secuencias genomicas de neisseria y procedimientos de uso.
WO2004055239A1 (en) * 2002-12-13 2004-07-01 Korea Power Engineering Company, Inc. Apparatus for cathodic protection in an environment in which thin film corrosive fluids are formed and method thereof
KR100485953B1 (ko) * 2002-12-13 2005-05-06 한국전력기술 주식회사 금속 구조물의 전기방식 방법

Also Published As

Publication number Publication date
FI913475L (fi) 1992-01-20
KR920002632A (ko) 1992-02-28
FI913475A7 (fi) 1992-01-20
CA2050635A1 (en) 1992-01-20
NO912823L (no) 1992-01-20
MX9100275A (es) 1992-02-28
NZ238974A (en) 1992-12-23
FI913475A0 (fi) 1991-07-18
PT98382A (pt) 1992-05-29
NO912823D0 (no) 1991-07-18
IL98839A0 (en) 1992-07-15
JPH0616569A (ja) 1994-01-25
AU8113691A (en) 1992-01-23

Similar Documents

Publication Publication Date Title
EP0467714A1 (en) The class II protein of the outer membrane of neisseria meningitidis
EP0186576B1 (en) Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
JP4827196B2 (ja) 髄膜炎菌類タンパク質ｎｍｂ１８７０のドメインおよびエピトープ
KR910002553B1 (ko) 폴리삭카라이드-단백질 결합체 및 이의 제조방법
CA1329766C (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
US5606030A (en) Coconjugates of OMPC, HIV related peptides and anionic moieties
EP0453024B1 (en) Actinobacillus pleuropneumoniae subunit vaccine
BE1000811A4 (fr) Anticorps monoclonaux, peptides et compositions les contenant, destinees au diagnostic et au traitement des infections par le virus hiv.
WO1993022343A1 (en) Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
JPH05260963A (ja) ペプチド−ポリサッカライド−蛋白質複合体ワクチン
JPH05306299A (ja) ナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白質とｈｉｖ−１関連ペプチドとの連結複合体、およびそれを含むワクチン
JPH03128399A (ja) エイズ用複合免疫原
AU624324B2 (en) Conjugate malaria vaccine
JPH04506666A (ja) ワクチンアジュバントとしてのｌｆａ―３
EP0166548A2 (en) Broad spectrum vaccine against gonorrhea
JPH0655679B2 (ja) 免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン
JPH04243896A (ja) 環状のｈｉｖ主要中和決定基ペプチド
JPH0656690A (ja) 免疫キャリア及び増強性質を有するネイセリア・メニンギチジスの外膜のクラスｉｉタンパク質
JPH05170797A (ja) 環状ｈｉｖ主要中和決定基ペプチド
JP2001505763A (ja) Ｈｉｖ ｐ―１７ペプチドフラグメント、それを含有する組成物並びにその製造及び使用方法
JPH0641197A (ja) 免疫キャリャー及び増強特性を有するナイセリアメニンギチジスの外層膜のクラスｉｉタンパク質
EP0547681A2 (en) Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a lipopeptide

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19950419